Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy

We aimed to determine whether the myocardial extracellular volume (ECV), measured using T1 measurements obtained during cardiac magnetic resonance imaging were increased in patients treated with anthracyclines. We performed cardiac magnetic resonance imaging and echocardiography and measured the ECV...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 2013-03, Vol.111 (5), p.717-722
Hauptverfasser: Neilan, Tomas G., MD, Coelho-Filho, Otavio R., MD, MPH, Shah, Ravi V., MD, Feng, Jiazuo H., BA, Pena-Herrera, Diego, Mandry, Damien, MD, Pierre-Mongeon, Francois, MD, Heydari, Bobak, MD, Francis, Sanjeev A., MD, Moslehi, Javid, MD, Kwong, Raymond Y., MD, MPH, Jerosch-Herold, Michael, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 722
container_issue 5
container_start_page 717
container_title The American journal of cardiology
container_volume 111
creator Neilan, Tomas G., MD
Coelho-Filho, Otavio R., MD, MPH
Shah, Ravi V., MD
Feng, Jiazuo H., BA
Pena-Herrera, Diego
Mandry, Damien, MD
Pierre-Mongeon, Francois, MD
Heydari, Bobak, MD
Francis, Sanjeev A., MD
Moslehi, Javid, MD
Kwong, Raymond Y., MD, MPH
Jerosch-Herold, Michael, PhD
description We aimed to determine whether the myocardial extracellular volume (ECV), measured using T1 measurements obtained during cardiac magnetic resonance imaging were increased in patients treated with anthracyclines. We performed cardiac magnetic resonance imaging and echocardiography and measured the ECV in 42 patients treated with anthracyclines. The data from the cardiac magnetic resonance study were compared to those from healthy volunteers. The anthracycline-treated cohort consisted of 21 men and 21 women with a mean age of 55 ± 17 years, who presented a median of 84 months after chemotherapy with a cumulative anthracycline exposure of 282 ± 65 mg/m2 and a mean left ventricular ejection fraction of 52 ± 12%. The ECV was elevated in the anthracycline-treated patients compared to the age- and gender-matched controls (0.36 ± 0.03 vs 0.28 ± 0.02, p
doi_str_mv 10.1016/j.amjcard.2012.11.022
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1400211322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002914912024551</els_id><sourcerecordid>3020371341</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-319e2b0d4c1131cf77ec4e6d4256de4a53d370c86ad025a63d0fcbc26896fdab3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EokvhJ4AscU7wOB-7uYDaVSmVWoGgwNGa2JNdL_lYbAc1J_46TncBiQsny5p3ntE8w9hzECkIKF_tUux2Gp1JpQCZAqRCygdsAatllUAF2UO2EELIpIK8OmFPvN_FL0BRPmYnMpNyVcl8wX7eTMNMsdjyi7vgUFPbji06_mVox454PfH1fV3zG9z0FKzmH8kPPfaa-FWHG9tvuO35BwyW-uD5rSMMZPhXG7b8rA_bCJ10a3tKztHHwnpL3RC25HA_PWWPGmw9PTu-p-zz24vb9bvk-v3l1frsOtF5VYQkg4pkLUyuATLQzXJJOqfS5LIoDeVYZCZbCr0q0QhZYJkZ0ehay3JVlY3BOjtlLw_cvRu-j-SD2g2j6-NIBXnUFLFSxlRxSGk3eO-oUXtnO3STAqFm7WqnjtrVrF0BKHHf9-JIH-uOzJ-u355j4M0hQHHHH5ac8jra0mSsIx2UGex_R7z-hzArtRrbbzSR_7uN8lIJ9Wm-_Xx6kELmRQHZL8sZrHg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1400211322</pqid></control><display><type>article</type><title>Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Neilan, Tomas G., MD ; Coelho-Filho, Otavio R., MD, MPH ; Shah, Ravi V., MD ; Feng, Jiazuo H., BA ; Pena-Herrera, Diego ; Mandry, Damien, MD ; Pierre-Mongeon, Francois, MD ; Heydari, Bobak, MD ; Francis, Sanjeev A., MD ; Moslehi, Javid, MD ; Kwong, Raymond Y., MD, MPH ; Jerosch-Herold, Michael, PhD</creator><creatorcontrib>Neilan, Tomas G., MD ; Coelho-Filho, Otavio R., MD, MPH ; Shah, Ravi V., MD ; Feng, Jiazuo H., BA ; Pena-Herrera, Diego ; Mandry, Damien, MD ; Pierre-Mongeon, Francois, MD ; Heydari, Bobak, MD ; Francis, Sanjeev A., MD ; Moslehi, Javid, MD ; Kwong, Raymond Y., MD, MPH ; Jerosch-Herold, Michael, PhD</creatorcontrib><description>We aimed to determine whether the myocardial extracellular volume (ECV), measured using T1 measurements obtained during cardiac magnetic resonance imaging were increased in patients treated with anthracyclines. We performed cardiac magnetic resonance imaging and echocardiography and measured the ECV in 42 patients treated with anthracyclines. The data from the cardiac magnetic resonance study were compared to those from healthy volunteers. The anthracycline-treated cohort consisted of 21 men and 21 women with a mean age of 55 ± 17 years, who presented a median of 84 months after chemotherapy with a cumulative anthracycline exposure of 282 ± 65 mg/m2 and a mean left ventricular ejection fraction of 52 ± 12%. The ECV was elevated in the anthracycline-treated patients compared to the age- and gender-matched controls (0.36 ± 0.03 vs 0.28 ± 0.02, p &lt;0.001). A positive association was found between the ECV and left atrial volume (ECV vs indexed left atrial volume, r = 0.65, p &lt;0.001), and negative association was found between the ECV and diastolic function (E′ lateral, r = −0.64, p &lt;0.001). In conclusion, the myocardial ECV is elevated in patients with previous anthracycline treatment and is associated with the diastolic function and increased atrial volumes.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2012.11.022</identifier><identifier>PMID: 23228924</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anthracyclines - adverse effects ; Anthracyclines - therapeutic use ; Cardiology ; Cardiomyopathies - chemically induced ; Cardiomyopathies - diagnosis ; Cardiomyopathies - physiopathology ; Cardiovascular ; Cardiovascular disease ; Chemotherapy ; Extracellular Space ; Female ; Heart attacks ; Heart failure ; Humans ; Lymphoma ; Magnetic Resonance Imaging, Cine - methods ; Male ; Mortality ; Myocardium - pathology ; Neoplasms - drug therapy ; Pulmonary arteries ; Retrospective Studies ; Stroke Volume - drug effects ; Ventricular Function, Left</subject><ispartof>The American journal of cardiology, 2013-03, Vol.111 (5), p.717-722</ispartof><rights>Elsevier Inc.</rights><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Mar 1, 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-319e2b0d4c1131cf77ec4e6d4256de4a53d370c86ad025a63d0fcbc26896fdab3</citedby><cites>FETCH-LOGICAL-c495t-319e2b0d4c1131cf77ec4e6d4256de4a53d370c86ad025a63d0fcbc26896fdab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002914912024551$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23228924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Neilan, Tomas G., MD</creatorcontrib><creatorcontrib>Coelho-Filho, Otavio R., MD, MPH</creatorcontrib><creatorcontrib>Shah, Ravi V., MD</creatorcontrib><creatorcontrib>Feng, Jiazuo H., BA</creatorcontrib><creatorcontrib>Pena-Herrera, Diego</creatorcontrib><creatorcontrib>Mandry, Damien, MD</creatorcontrib><creatorcontrib>Pierre-Mongeon, Francois, MD</creatorcontrib><creatorcontrib>Heydari, Bobak, MD</creatorcontrib><creatorcontrib>Francis, Sanjeev A., MD</creatorcontrib><creatorcontrib>Moslehi, Javid, MD</creatorcontrib><creatorcontrib>Kwong, Raymond Y., MD, MPH</creatorcontrib><creatorcontrib>Jerosch-Herold, Michael, PhD</creatorcontrib><title>Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>We aimed to determine whether the myocardial extracellular volume (ECV), measured using T1 measurements obtained during cardiac magnetic resonance imaging were increased in patients treated with anthracyclines. We performed cardiac magnetic resonance imaging and echocardiography and measured the ECV in 42 patients treated with anthracyclines. The data from the cardiac magnetic resonance study were compared to those from healthy volunteers. The anthracycline-treated cohort consisted of 21 men and 21 women with a mean age of 55 ± 17 years, who presented a median of 84 months after chemotherapy with a cumulative anthracycline exposure of 282 ± 65 mg/m2 and a mean left ventricular ejection fraction of 52 ± 12%. The ECV was elevated in the anthracycline-treated patients compared to the age- and gender-matched controls (0.36 ± 0.03 vs 0.28 ± 0.02, p &lt;0.001). A positive association was found between the ECV and left atrial volume (ECV vs indexed left atrial volume, r = 0.65, p &lt;0.001), and negative association was found between the ECV and diastolic function (E′ lateral, r = −0.64, p &lt;0.001). In conclusion, the myocardial ECV is elevated in patients with previous anthracycline treatment and is associated with the diastolic function and increased atrial volumes.</description><subject>Anthracyclines - adverse effects</subject><subject>Anthracyclines - therapeutic use</subject><subject>Cardiology</subject><subject>Cardiomyopathies - chemically induced</subject><subject>Cardiomyopathies - diagnosis</subject><subject>Cardiomyopathies - physiopathology</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Chemotherapy</subject><subject>Extracellular Space</subject><subject>Female</subject><subject>Heart attacks</subject><subject>Heart failure</subject><subject>Humans</subject><subject>Lymphoma</subject><subject>Magnetic Resonance Imaging, Cine - methods</subject><subject>Male</subject><subject>Mortality</subject><subject>Myocardium - pathology</subject><subject>Neoplasms - drug therapy</subject><subject>Pulmonary arteries</subject><subject>Retrospective Studies</subject><subject>Stroke Volume - drug effects</subject><subject>Ventricular Function, Left</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkU1v1DAQhi0EokvhJ4AscU7wOB-7uYDaVSmVWoGgwNGa2JNdL_lYbAc1J_46TncBiQsny5p3ntE8w9hzECkIKF_tUux2Gp1JpQCZAqRCygdsAatllUAF2UO2EELIpIK8OmFPvN_FL0BRPmYnMpNyVcl8wX7eTMNMsdjyi7vgUFPbji06_mVox454PfH1fV3zG9z0FKzmH8kPPfaa-FWHG9tvuO35BwyW-uD5rSMMZPhXG7b8rA_bCJ10a3tKztHHwnpL3RC25HA_PWWPGmw9PTu-p-zz24vb9bvk-v3l1frsOtF5VYQkg4pkLUyuATLQzXJJOqfS5LIoDeVYZCZbCr0q0QhZYJkZ0ehay3JVlY3BOjtlLw_cvRu-j-SD2g2j6-NIBXnUFLFSxlRxSGk3eO-oUXtnO3STAqFm7WqnjtrVrF0BKHHf9-JIH-uOzJ-u355j4M0hQHHHH5ac8jra0mSsIx2UGex_R7z-hzArtRrbbzSR_7uN8lIJ9Wm-_Xx6kELmRQHZL8sZrHg</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>Neilan, Tomas G., MD</creator><creator>Coelho-Filho, Otavio R., MD, MPH</creator><creator>Shah, Ravi V., MD</creator><creator>Feng, Jiazuo H., BA</creator><creator>Pena-Herrera, Diego</creator><creator>Mandry, Damien, MD</creator><creator>Pierre-Mongeon, Francois, MD</creator><creator>Heydari, Bobak, MD</creator><creator>Francis, Sanjeev A., MD</creator><creator>Moslehi, Javid, MD</creator><creator>Kwong, Raymond Y., MD, MPH</creator><creator>Jerosch-Herold, Michael, PhD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20130301</creationdate><title>Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy</title><author>Neilan, Tomas G., MD ; Coelho-Filho, Otavio R., MD, MPH ; Shah, Ravi V., MD ; Feng, Jiazuo H., BA ; Pena-Herrera, Diego ; Mandry, Damien, MD ; Pierre-Mongeon, Francois, MD ; Heydari, Bobak, MD ; Francis, Sanjeev A., MD ; Moslehi, Javid, MD ; Kwong, Raymond Y., MD, MPH ; Jerosch-Herold, Michael, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-319e2b0d4c1131cf77ec4e6d4256de4a53d370c86ad025a63d0fcbc26896fdab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Anthracyclines - adverse effects</topic><topic>Anthracyclines - therapeutic use</topic><topic>Cardiology</topic><topic>Cardiomyopathies - chemically induced</topic><topic>Cardiomyopathies - diagnosis</topic><topic>Cardiomyopathies - physiopathology</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Chemotherapy</topic><topic>Extracellular Space</topic><topic>Female</topic><topic>Heart attacks</topic><topic>Heart failure</topic><topic>Humans</topic><topic>Lymphoma</topic><topic>Magnetic Resonance Imaging, Cine - methods</topic><topic>Male</topic><topic>Mortality</topic><topic>Myocardium - pathology</topic><topic>Neoplasms - drug therapy</topic><topic>Pulmonary arteries</topic><topic>Retrospective Studies</topic><topic>Stroke Volume - drug effects</topic><topic>Ventricular Function, Left</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Neilan, Tomas G., MD</creatorcontrib><creatorcontrib>Coelho-Filho, Otavio R., MD, MPH</creatorcontrib><creatorcontrib>Shah, Ravi V., MD</creatorcontrib><creatorcontrib>Feng, Jiazuo H., BA</creatorcontrib><creatorcontrib>Pena-Herrera, Diego</creatorcontrib><creatorcontrib>Mandry, Damien, MD</creatorcontrib><creatorcontrib>Pierre-Mongeon, Francois, MD</creatorcontrib><creatorcontrib>Heydari, Bobak, MD</creatorcontrib><creatorcontrib>Francis, Sanjeev A., MD</creatorcontrib><creatorcontrib>Moslehi, Javid, MD</creatorcontrib><creatorcontrib>Kwong, Raymond Y., MD, MPH</creatorcontrib><creatorcontrib>Jerosch-Herold, Michael, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Neilan, Tomas G., MD</au><au>Coelho-Filho, Otavio R., MD, MPH</au><au>Shah, Ravi V., MD</au><au>Feng, Jiazuo H., BA</au><au>Pena-Herrera, Diego</au><au>Mandry, Damien, MD</au><au>Pierre-Mongeon, Francois, MD</au><au>Heydari, Bobak, MD</au><au>Francis, Sanjeev A., MD</au><au>Moslehi, Javid, MD</au><au>Kwong, Raymond Y., MD, MPH</au><au>Jerosch-Herold, Michael, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2013-03-01</date><risdate>2013</risdate><volume>111</volume><issue>5</issue><spage>717</spage><epage>722</epage><pages>717-722</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>We aimed to determine whether the myocardial extracellular volume (ECV), measured using T1 measurements obtained during cardiac magnetic resonance imaging were increased in patients treated with anthracyclines. We performed cardiac magnetic resonance imaging and echocardiography and measured the ECV in 42 patients treated with anthracyclines. The data from the cardiac magnetic resonance study were compared to those from healthy volunteers. The anthracycline-treated cohort consisted of 21 men and 21 women with a mean age of 55 ± 17 years, who presented a median of 84 months after chemotherapy with a cumulative anthracycline exposure of 282 ± 65 mg/m2 and a mean left ventricular ejection fraction of 52 ± 12%. The ECV was elevated in the anthracycline-treated patients compared to the age- and gender-matched controls (0.36 ± 0.03 vs 0.28 ± 0.02, p &lt;0.001). A positive association was found between the ECV and left atrial volume (ECV vs indexed left atrial volume, r = 0.65, p &lt;0.001), and negative association was found between the ECV and diastolic function (E′ lateral, r = −0.64, p &lt;0.001). In conclusion, the myocardial ECV is elevated in patients with previous anthracycline treatment and is associated with the diastolic function and increased atrial volumes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23228924</pmid><doi>10.1016/j.amjcard.2012.11.022</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2013-03, Vol.111 (5), p.717-722
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_journals_1400211322
source MEDLINE; Elsevier ScienceDirect Journals
subjects Anthracyclines - adverse effects
Anthracyclines - therapeutic use
Cardiology
Cardiomyopathies - chemically induced
Cardiomyopathies - diagnosis
Cardiomyopathies - physiopathology
Cardiovascular
Cardiovascular disease
Chemotherapy
Extracellular Space
Female
Heart attacks
Heart failure
Humans
Lymphoma
Magnetic Resonance Imaging, Cine - methods
Male
Mortality
Myocardium - pathology
Neoplasms - drug therapy
Pulmonary arteries
Retrospective Studies
Stroke Volume - drug effects
Ventricular Function, Left
title Myocardial Extracellular Volume by Cardiac Magnetic Resonance Imaging in Patients Treated With Anthracycline-Based Chemotherapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T20%3A24%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myocardial%20Extracellular%20Volume%20by%20Cardiac%20Magnetic%20Resonance%20Imaging%20in%20Patients%20Treated%20With%20Anthracycline-Based%20Chemotherapy&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Neilan,%20Tomas%20G.,%20MD&rft.date=2013-03-01&rft.volume=111&rft.issue=5&rft.spage=717&rft.epage=722&rft.pages=717-722&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2012.11.022&rft_dat=%3Cproquest_cross%3E3020371341%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1400211322&rft_id=info:pmid/23228924&rft_els_id=1_s2_0_S0002914912024551&rfr_iscdi=true